Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tandem Mass Spectrometry | 7 | 2024 | 1189 | 1.630 |
Why?
|
Chromatography, High Pressure Liquid | 5 | 2024 | 1549 | 1.530 |
Why?
|
Hyperammonemia | 4 | 2021 | 78 | 1.470 |
Why?
|
Chromatography, Liquid | 5 | 2024 | 987 | 1.160 |
Why?
|
Acidosis | 3 | 2020 | 271 | 1.140 |
Why?
|
Carnitine | 3 | 2021 | 252 | 1.040 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 3 | 2020 | 282 | 1.020 |
Why?
|
Neonatal Screening | 4 | 2016 | 596 | 1.000 |
Why?
|
Gas Chromatography-Mass Spectrometry | 6 | 2017 | 352 | 0.790 |
Why?
|
Hyperhomocysteinemia | 1 | 2022 | 118 | 0.770 |
Why?
|
Urea Cycle Disorders, Inborn | 2 | 2020 | 32 | 0.720 |
Why?
|
Busulfan | 2 | 2020 | 258 | 0.710 |
Why?
|
Saxitoxin | 2 | 2016 | 65 | 0.670 |
Why?
|
Glycerol Kinase | 1 | 2018 | 17 | 0.650 |
Why?
|
Metabolism, Inborn Errors | 2 | 2020 | 285 | 0.640 |
Why?
|
Isoleucine | 1 | 2018 | 110 | 0.640 |
Why?
|
Amino Acids | 3 | 2016 | 1715 | 0.630 |
Why?
|
Malonates | 1 | 2017 | 43 | 0.600 |
Why?
|
Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2017 | 23 | 0.590 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2017 | 45 | 0.590 |
Why?
|
Glycerol | 1 | 2018 | 277 | 0.580 |
Why?
|
Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 1 | 2017 | 6 | 0.580 |
Why?
|
Alkaptonuria | 1 | 2017 | 13 | 0.570 |
Why?
|
Anions | 1 | 2017 | 137 | 0.570 |
Why?
|
Tyrosinemias | 1 | 2016 | 10 | 0.570 |
Why?
|
Purpura | 1 | 2017 | 116 | 0.560 |
Why?
|
Carbon-Carbon Ligases | 1 | 2016 | 19 | 0.560 |
Why?
|
Glutaryl-CoA Dehydrogenase | 1 | 2016 | 19 | 0.560 |
Why?
|
Vitamin A | 1 | 2020 | 613 | 0.550 |
Why?
|
Adrenal Insufficiency | 1 | 2018 | 192 | 0.550 |
Why?
|
Brain Diseases, Metabolic | 1 | 2016 | 44 | 0.540 |
Why?
|
Spasm | 1 | 2016 | 131 | 0.530 |
Why?
|
Lysosomal Storage Diseases | 1 | 2016 | 79 | 0.530 |
Why?
|
Color | 1 | 2017 | 298 | 0.520 |
Why?
|
Neuromuscular Blocking Agents | 1 | 2016 | 130 | 0.510 |
Why?
|
Vitamin E | 1 | 2020 | 872 | 0.510 |
Why?
|
Urine | 1 | 2017 | 363 | 0.500 |
Why?
|
Genetic Diseases, Inborn | 1 | 2020 | 601 | 0.500 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2016 | 159 | 0.500 |
Why?
|
Seizures | 3 | 2020 | 2916 | 0.490 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2017 | 227 | 0.490 |
Why?
|
Serine | 1 | 2018 | 831 | 0.460 |
Why?
|
Transketolase | 1 | 2013 | 9 | 0.450 |
Why?
|
Laboratories | 2 | 2020 | 461 | 0.450 |
Why?
|
Hypoglycemia | 2 | 2020 | 888 | 0.440 |
Why?
|
Growth Disorders | 1 | 2018 | 654 | 0.440 |
Why?
|
Magnesium Sulfate | 1 | 2013 | 73 | 0.430 |
Why?
|
Clinical Chemistry Tests | 1 | 2013 | 59 | 0.430 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 704 | 0.430 |
Why?
|
Dystonia | 1 | 2016 | 364 | 0.420 |
Why?
|
Thiamine | 1 | 2013 | 160 | 0.400 |
Why?
|
Metabolomics | 2 | 2023 | 1626 | 0.390 |
Why?
|
Rare Diseases | 1 | 2017 | 619 | 0.380 |
Why?
|
Diarrhea | 1 | 2018 | 1341 | 0.380 |
Why?
|
Blood Chemical Analysis | 1 | 2013 | 437 | 0.380 |
Why?
|
Vitamin B Complex | 1 | 2013 | 297 | 0.370 |
Why?
|
Parkinson Disease | 2 | 2022 | 2853 | 0.370 |
Why?
|
Anesthetics | 1 | 2016 | 522 | 0.370 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2017 | 819 | 0.370 |
Why?
|
Hearing Loss | 1 | 2018 | 780 | 0.360 |
Why?
|
Drug Monitoring | 2 | 2024 | 966 | 0.360 |
Why?
|
Developmental Disabilities | 1 | 2018 | 1504 | 0.340 |
Why?
|
Acidosis, Lactic | 2 | 2021 | 145 | 0.340 |
Why?
|
Clinical Laboratory Techniques | 1 | 2015 | 749 | 0.330 |
Why?
|
Communicable Disease Control | 1 | 2014 | 844 | 0.300 |
Why?
|
Liver Diseases | 1 | 2016 | 1301 | 0.300 |
Why?
|
Mass Spectrometry | 1 | 2015 | 2192 | 0.290 |
Why?
|
Immunosuppressive Agents | 2 | 2020 | 4168 | 0.270 |
Why?
|
Communicable Diseases | 1 | 2014 | 879 | 0.270 |
Why?
|
Teaching | 1 | 2013 | 1167 | 0.260 |
Why?
|
Infant, Newborn | 8 | 2021 | 26169 | 0.250 |
Why?
|
Disease Outbreaks | 1 | 2014 | 1759 | 0.250 |
Why?
|
Learning | 1 | 2013 | 1733 | 0.230 |
Why?
|
Child, Preschool | 9 | 2020 | 42036 | 0.230 |
Why?
|
Population Surveillance | 1 | 2014 | 2609 | 0.230 |
Why?
|
Erythrocytes | 1 | 2013 | 2415 | 0.230 |
Why?
|
Cotinine | 2 | 2015 | 203 | 0.220 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2696 | 0.220 |
Why?
|
Mucopolysaccharidoses | 1 | 2023 | 27 | 0.210 |
Why?
|
Alcoholism | 1 | 2013 | 1961 | 0.210 |
Why?
|
Humans | 42 | 2024 | 760276 | 0.210 |
Why?
|
Anticonvulsants | 2 | 2024 | 1881 | 0.200 |
Why?
|
Heparitin Sulfate | 1 | 2023 | 224 | 0.200 |
Why?
|
Internet | 1 | 2013 | 3074 | 0.190 |
Why?
|
Gaucher Disease | 1 | 2022 | 110 | 0.190 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2020 | 40 | 0.180 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 2021 | 120 | 0.180 |
Why?
|
Thiolester Hydrolases | 1 | 2020 | 85 | 0.170 |
Why?
|
DAX-1 Orphan Nuclear Receptor | 1 | 2018 | 29 | 0.160 |
Why?
|
Tobacco Smoke Pollution | 2 | 2015 | 810 | 0.150 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 53 | 0.150 |
Why?
|
Galactosemias | 1 | 2018 | 124 | 0.150 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2017 | 73 | 0.150 |
Why?
|
Anemia, Sideroblastic | 1 | 2018 | 109 | 0.150 |
Why?
|
Heptanoates | 1 | 2016 | 4 | 0.140 |
Why?
|
Nitrobenzoates | 1 | 2016 | 16 | 0.140 |
Why?
|
Acids, Acyclic | 1 | 2016 | 3 | 0.140 |
Why?
|
Hydroxocobalamin | 1 | 2016 | 27 | 0.140 |
Why?
|
Cyclohexanones | 1 | 2016 | 29 | 0.140 |
Why?
|
Barth Syndrome | 1 | 2017 | 25 | 0.140 |
Why?
|
Solid Phase Extraction | 1 | 2016 | 30 | 0.140 |
Why?
|
Syndrome | 2 | 2020 | 3278 | 0.140 |
Why?
|
Carboxylic Acids | 1 | 2017 | 90 | 0.140 |
Why?
|
Acid-Base Equilibrium | 1 | 2017 | 180 | 0.140 |
Why?
|
Male | 18 | 2020 | 359427 | 0.140 |
Why?
|
Reference Standards | 1 | 2020 | 1004 | 0.130 |
Why?
|
Limit of Detection | 1 | 2016 | 280 | 0.130 |
Why?
|
Workflow | 1 | 2020 | 851 | 0.120 |
Why?
|
Acyltransferases | 1 | 2017 | 306 | 0.120 |
Why?
|
Arginine | 1 | 2018 | 934 | 0.120 |
Why?
|
Glutarates | 1 | 2016 | 244 | 0.120 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2018 | 378 | 0.120 |
Why?
|
Urinalysis | 1 | 2016 | 368 | 0.120 |
Why?
|
Adolescent | 8 | 2020 | 87749 | 0.110 |
Why?
|
Scotland | 1 | 2013 | 144 | 0.110 |
Why?
|
Chromatography, Ion Exchange | 2 | 2013 | 297 | 0.110 |
Why?
|
Anesthesia, Local | 1 | 2015 | 276 | 0.110 |
Why?
|
Thiamine Deficiency | 1 | 2013 | 48 | 0.110 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 857 | 0.110 |
Why?
|
Liver Regeneration | 1 | 2014 | 213 | 0.100 |
Why?
|
Abnormalities, Multiple | 1 | 2020 | 1416 | 0.100 |
Why?
|
Iodide Peroxidase | 1 | 2014 | 294 | 0.100 |
Why?
|
Mutation | 6 | 2021 | 29951 | 0.100 |
Why?
|
Diagnosis | 1 | 2013 | 157 | 0.100 |
Why?
|
Cyclosporine | 1 | 2015 | 778 | 0.100 |
Why?
|
Bupivacaine | 1 | 2015 | 413 | 0.100 |
Why?
|
Epinephrine | 1 | 2015 | 791 | 0.100 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2021 | 1300 | 0.100 |
Why?
|
Mitochondrial Proteins | 1 | 2017 | 979 | 0.100 |
Why?
|
Tacrolimus | 1 | 2015 | 730 | 0.100 |
Why?
|
Reproducibility of Results | 3 | 2024 | 20045 | 0.090 |
Why?
|
Arrhythmias, Cardiac | 1 | 2021 | 2253 | 0.090 |
Why?
|
Child | 7 | 2021 | 79759 | 0.080 |
Why?
|
Saliva | 1 | 2014 | 816 | 0.080 |
Why?
|
Vulnerable Populations | 1 | 2015 | 696 | 0.080 |
Why?
|
Mutation, Missense | 1 | 2018 | 2563 | 0.080 |
Why?
|
Infusions, Intravenous | 1 | 2013 | 2235 | 0.080 |
Why?
|
Epilepsy | 1 | 2024 | 3267 | 0.080 |
Why?
|
Sirolimus | 1 | 2015 | 1548 | 0.070 |
Why?
|
Disease | 1 | 2013 | 671 | 0.070 |
Why?
|
Female | 13 | 2021 | 391024 | 0.070 |
Why?
|
Hepatocytes | 1 | 2014 | 1228 | 0.070 |
Why?
|
Genetic Testing | 1 | 2020 | 3533 | 0.070 |
Why?
|
Drug Therapy, Combination | 2 | 2015 | 6499 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 3726 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16543 | 0.060 |
Why?
|
Asthma | 2 | 2015 | 6167 | 0.060 |
Why?
|
Diagnostic Errors | 1 | 2012 | 1266 | 0.060 |
Why?
|
Infant | 5 | 2020 | 36032 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5508 | 0.050 |
Why?
|
Vitamin D | 1 | 2017 | 3293 | 0.050 |
Why?
|
Dermatan Sulfate | 1 | 2023 | 43 | 0.050 |
Why?
|
Poverty | 1 | 2015 | 2695 | 0.050 |
Why?
|
Glucosylceramidase | 1 | 2022 | 125 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12968 | 0.050 |
Why?
|
Glycosaminoglycans | 1 | 2023 | 606 | 0.040 |
Why?
|
Cohort Studies | 2 | 2020 | 41316 | 0.040 |
Why?
|
Ammonia | 1 | 2020 | 236 | 0.040 |
Why?
|
Patient Readmission | 1 | 2014 | 3329 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7510 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2016 | 64968 | 0.040 |
Why?
|
Urea | 1 | 2020 | 445 | 0.040 |
Why?
|
Galactose | 1 | 2018 | 297 | 0.040 |
Why?
|
Receptors, Thyrotropin | 1 | 1997 | 45 | 0.040 |
Why?
|
Transcription Factors | 1 | 2017 | 12100 | 0.040 |
Why?
|
Aspartic Acid | 1 | 2018 | 576 | 0.030 |
Why?
|
Young Adult | 3 | 2020 | 58673 | 0.030 |
Why?
|
alpha-Synuclein | 1 | 2022 | 749 | 0.030 |
Why?
|
Hypesthesia | 1 | 2015 | 107 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 2021 | 1036 | 0.030 |
Why?
|
Carbon Tetrachloride | 1 | 2014 | 72 | 0.030 |
Why?
|
Toxins, Biological | 1 | 2014 | 61 | 0.030 |
Why?
|
Adult | 4 | 2020 | 219843 | 0.030 |
Why?
|
Ohio | 1 | 2015 | 333 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3302 | 0.030 |
Why?
|
Point Mutation | 1 | 2018 | 1594 | 0.030 |
Why?
|
Heart Failure | 1 | 2017 | 11836 | 0.030 |
Why?
|
Thyroglobulin | 1 | 1970 | 111 | 0.020 |
Why?
|
Necrosis | 1 | 2014 | 1612 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4110 | 0.020 |
Why?
|
Organ Specificity | 1 | 2014 | 1955 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2717 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 2015 | 1001 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4089 | 0.020 |
Why?
|
Autoantibodies | 1 | 1997 | 2118 | 0.020 |
Why?
|
Iodine | 1 | 1970 | 286 | 0.020 |
Why?
|
Glutathione | 1 | 1970 | 582 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10185 | 0.020 |
Why?
|
Thyroid Gland | 2 | 1970 | 1169 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8487 | 0.020 |
Why?
|
Pain Measurement | 1 | 2015 | 3514 | 0.020 |
Why?
|
Middle Aged | 2 | 2020 | 220179 | 0.010 |
Why?
|
Recovery of Function | 1 | 2014 | 2983 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10828 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 18968 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2015 | 12412 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 80311 | 0.010 |
Why?
|
Prospective Studies | 2 | 2015 | 54265 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14396 | 0.010 |
Why?
|
Proteins | 2 | 1970 | 6030 | 0.010 |
Why?
|
Immunoglobulins, Thyroid-Stimulating | 1 | 1997 | 34 | 0.010 |
Why?
|
Spodoptera | 1 | 1997 | 141 | 0.010 |
Why?
|
Baculoviridae | 1 | 1997 | 115 | 0.010 |
Why?
|
Antigen-Antibody Reactions | 1 | 1997 | 346 | 0.010 |
Why?
|
Carbohydrate Sequence | 1 | 1997 | 410 | 0.010 |
Why?
|
Thyrotropin | 2 | 1970 | 832 | 0.010 |
Why?
|
Hospitalization | 1 | 2015 | 10761 | 0.010 |
Why?
|
Glycosylation | 1 | 1997 | 1097 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1997 | 1993 | 0.010 |
Why?
|
Iodoproteins | 1 | 1970 | 2 | 0.010 |
Why?
|
Iodine Isotopes | 1 | 1970 | 86 | 0.010 |
Why?
|
Mice | 2 | 2014 | 81212 | 0.010 |
Why?
|
Rabbits | 1 | 1997 | 4773 | 0.010 |
Why?
|
Centrifugation, Density Gradient | 1 | 1970 | 299 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 3806 | 0.010 |
Why?
|
Animals | 4 | 2014 | 167935 | 0.000 |
Why?
|
Dogs | 2 | 1970 | 3842 | 0.000 |
Why?
|
Aged | 1 | 2020 | 169002 | 0.000 |
Why?
|
Peptide Hydrolases | 1 | 1970 | 623 | 0.000 |
Why?
|
Genetic Vectors | 1 | 1997 | 3378 | 0.000 |
Why?
|
Cathepsins | 1 | 1966 | 242 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1997 | 13456 | 0.000 |
Why?
|
Thyroidectomy | 1 | 1970 | 903 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1997 | 17628 | 0.000 |
Why?
|
Lysosomes | 1 | 1966 | 919 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1966 | 2509 | 0.000 |
Why?
|
Concepts
(226)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_